West Nile Virus M glycoprotein peptide (ab39904)

製品の概要

  • 製品名West Nile Virus M glycoprotein peptide

製品の詳細

  • 由来Synthetic

特性

Our Abpromise guarantee covers the use of ab39904 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Blocking

    ELISA

  • 製品の状態Liquid
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Preservative: 0.02% Sodium Azide
    Constituents: 0.1% BSA, PBS, pH 7.2

関連情報

  • 別名
    • Envelope protein M
    • Matrix protein
    • West Nile virus matrix protein
    • WNV matrix protein
  • 関連性West Nile (WN), the most widespread among flaviviruses, was first isolated from the serum of a febrile woman in 1937 in the West Nile district of Uganda. West Nile virus was first detected in North America in 1999 and has subsequently spread throughout the United States and Canada and into Mexico and the Caribbean. In Africa, southern Europe, western Asia, and the United States, WNV has been isolated from mosquitoes of more than 40 species. In the United States, Canada, and Israel, WNV is responsible for significant avian mortality.

West Nile Virus M glycoprotein peptide (ab39904) 使用論文

ab39904 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab39904.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"